22157.jpg
Exosome Diagnostics and Therapeutics - Global Market Size & Market Share Analysis by Application, End-user, and Geographic Region: 2019-2026
November 25, 2021 05:38 ET | Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics and Therapeutics: Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for...
22157.jpg
Global Genetic Testing Market Report 2021: Market to Reach $17.3 Billion by 2026 - Predictive & Presymptomatic Segment to Reach $3 Billion
July 13, 2021 03:33 ET | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Genetic Testing Market...
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
November 10, 2017 16:15 ET | CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
August 03, 2017 06:00 ET | CombiMatrix Corporation
IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present at Upcoming Investor Conferences
May 22, 2017 06:00 ET | CombiMatrix Corporation
IRVINE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results
May 04, 2017 16:05 ET | CombiMatrix Corporation
Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections ...
CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017
April 27, 2017 06:00 ET | CombiMatrix Corporation
IRVINE, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
March 01, 2017 06:00 ET | CombiMatrix Corporation
IRVINE, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
February 22, 2017 16:05 ET | CombiMatrix Corporation
Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record...
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
February 15, 2017 06:00 ET | CombiMatrix Corporation
IRVINE, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...